Not Signed In -
Carbamazepine |
Atretol; Epitol; Tegretol |
Clinical Trial: Carbamazepine Treatment of Cocaine Dependence - 1
This study has been completed.
Purpose
The purpose of this study is to compare the efficacy of carbamazepine in treatment of cocaine-dependence in patients with affective disorders.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Cocaine-Related Disorders Substance-Related Disorders | Drug: Carbamazepine | Phase II |
MedlinePlus related topics: Cocaine Abuse; Drug Abuse; Prescription Drug Abuse
Study Type: Interventional
Study Design: Treatment, Uncontrolled
Official Title: Carbamazepine Treatment of Cocaine Dependence
Study start: October 1992; Study completion: July 1996
Eligibility
Ages Eligible for Study: 18 Years - 65 Years, Genders Eligible for Study: Both
Criteria
Location Information
South Carolina
Medical University of South Carolina, Charleston, South Carolina, 29425 742, United States
Kathleen Brady, Ph.D., Principal Investigator, Medical University of South Carolina
More Information
Publications
(1) Brady KT et. al. Features of cocaine dependence with concurrent alcohol abuse. Drug and Alcohol Depend. 1995, 39(1):69-71. (2) Brady KT et. al. Personality disorder and assault history in substance-dependent individuals. Am J on Addictions. 1995, 4(4):306-312. (3) Dansky et. al. Use of self-report measures of crime-related posttraumatic stress disorder with substance use disordered patients. Journal of Substance Abuse Treatment. (in press). (4) Sonne an Presentation at CPDD meeting, 1996.
Record last reviewed: July 1996
Last Updated: February 15, 2005
Record first received: September 20, 1999
ClinicalTrials.gov Identifier: NCT00000242
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 8, 2005
Resources
- Atretol (Drug Digest)
- Carbamazepine (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
